Trial intelligence / Profile preview

Tranexamic acid for control of post-surgical drainage after neck dissection in oral cancer

IRCT20231019059765N1Phase 4Completed

Sponsor
CMH Lahore Medical College and Institute of Dentistry
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tranexamic acid in mouth cancer, sponsored by CMH Lahore Medical College and Institute of Dentistry. Primary endpoint: Post-surgical neck drain output. Started Dec 2023; status: completed.

02

Drugs

tranexamic acid
03

Conditions

mouth cancer

Beyond the preview

Go deeper on IRCT20231019059765N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20231019059765N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call